NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel ...

NeuroSense Therapeutics (NRSN) announced the issuance of a patent by the USPTO, entitled 'Compositions comprising Ciprofloxacin and ...

The interaction of celecoxib and rofecoxib with warfarin was studied. Patients stable on warfarin therapy and concurrently taking a cyclooxygenase-2 (COX-2) inhibitor comparator (traditional ...

NeuroSense Therapeutics has been granted a key patent for the formulation of its treatment for amyotrophic lateral sclerosis, or ALS.

All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for ...

COX-1 protects the stomach lining and regulates blood platelets, while COX-2 is primarily associated with inflammation and ...

We evaluated opioid-sparing effects and rehabilitative results after perioperative celecoxib administration for total knee arthroplasty. Methods: This was a prospective, randomized, observer-blind ...

A meta-analysis reveals triptans as the most effective acute migraine treatments, highlighting the need for their inclusion ...

It was three years before it subsided. I still have tinnitus, but it’s livable now. A. When most health care professionals ...

A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...